FDA upgrades Jubilant Life's US plant status

Last Updated: Friday, June 12, 2015, 14:24

This upgradation by the USFDA from Official Action Indicated (OAI) to VAI is "indicative of the current good manufacturing practice (cGMP) status at the facility" since receiving the warning letter in 2013, the drug maker added.

Novartis India arm says unaware of any delisting plan

Last Updated: Thursday, June 11, 2015, 19:51

"The board of the company has not received any notice from the promoters of the company, Novartis AG, on its intention to delist the equity shares of the company from the Bombay Stock Exchange Limited," Novartis India said in a statement after trading hours.

Govt exhorts pharma firms to invest more in R&D

Last Updated: Friday, June 5, 2015, 15:19

Government on Friday urged pharmaceutical companies to increase investment in research and development (R&D) to emerge as a hub of innovation in low cost health products and services.

Sun Pharma shareholders approve amalgamation scheme

Last Updated: Friday, June 5, 2015, 14:58

Sun Pharmaceutical on Friday said court convened meeting of its shareholders has approved the scheme of amalgamation of Sun Pharma Global Inc with itself.

'Pharma industry grappling with pricing, regulatory issues'

Last Updated: Wednesday, June 3, 2015, 21:12

The buoyant pharmaceutical industry is still struggling to deal with the challenges around pricing in the domestic market, increased regulations as well as data integrity, says an EY survey.

Cipla gets USFDA nod for Lopinavir, Ritonavir oral pellets

Last Updated: Wednesday, June 3, 2015, 17:06

The company stock closed at Rs 634.90, down 0.95 per cent, on the BSE.

Teva poised to raise its stake in Mylan: Sources

Last Updated: Wednesday, June 3, 2015, 10:12

The strategy is a sign of Teva`s commitment to its $40 billion bid for Mylan, as the latter presses on with its own $34 billion hostile bid for over-the-counter drug company Perrigo Company Plc .

Sun Pharma, AstraZeneca seal distribution deal

Last Updated: Tuesday, June 2, 2015, 12:32

Drug majors Sun Pharmaceutical and AstraZeneca Pharma India (AZPIL) on Tuesday said they have entered into a distribution services agreement to distribute AstraZeneca's heart disease treatment drug 'Axcer' in India.

Sun Pharma shares tank 9%; m-cap down Rs 20,864 cr post Q4 results

Last Updated: Monday, June 1, 2015, 18:19

Shares of Sun Pharmaceutical Industries plunged over 9 percent Monday, wiping out Rs 20,864 crore from its market valuation, after the company's fourth quarter earnings came below market expectations.

High Court stays Rs 1.35 cr demand slapped on Novartis by NPPA

Last Updated: Monday, June 1, 2015, 17:15

Novartis, in its plea, claimed that the government by a June 14, 2013 notification had revised the price of its drug, Regestrone, used for regulating women's menstrual cycle.

Sun Pharma shares tank 11%; top loser on Sensex, Nifty

Last Updated: Monday, June 1, 2015, 12:24

The stock plunged 11 percent to Rs 869.50 on the BSE. At the NSE, it dipped 10 percent to Rs 869.10.

Teva to pay $1.2 bn fine to settle US antitrust case

Last Updated: Thursday, May 28, 2015, 22:21

Teva Pharmaceutical will pay $1.2 billion to settle US antitrust charges in a long-running "pay for delay" case involving Cephalon, which Teva acquired in 2012, the Federal Trade Commission said Thursday.